Canada markets closed

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.2190-0.0190 (-1.53%)
At close: 11:32AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.2380
Open1.2300
BidN/A x N/A
AskN/A x N/A
Day's Range1.2190 - 1.2300
52 Week Range0.8380 - 2.5620
Volume8,031
Avg. Volume18,396
Market Cap30.143M
Beta (5Y Monthly)1.87
PE Ratio (TTM)4.20
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    FDA Approves Medexus's Supplemental Biologics License Application for IXINITY(R) to Treat Hemophilia B in Pediatric Patients

    Expanded indication includes patients under 12 years of age, based on Phase 3/4 data demonstrating safety and efficacy in previously treated patients in this age group Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 26, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced that the US Food and Drug Administration (FDA) recently approved Medexus's supplemental Biologics License Application (sBLA) for IXINITY® [coagulation factor IX (recombinant)] for the on-dem

  • Newsfile

    Medexus Announces Fiscal Q3 2024 Results

    Fiscal Q3 2024 revenue of $25.2 million, Operating income of $1.6 million, and Adjusted EBITDA* of $3.2 millionManagement to host conference call at 8:00 AM Eastern time on Thursday, February 8, 2024Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 7, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced its operating and financial results and provided a business update for the company's third fiscal quarter ended December 31, 2023 (the company's fiscal Q3 ..

  • Newsfile

    Medexus Schedules Third Fiscal Quarter 2024 Conference Call

    Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 30, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, February 8, 2024 to discuss Medexus's results for its third fiscal quarter ended December 31, 2023. Medexus expects to file its financial statements and MD&A after markets close on February 7, 2024.To participate in the call, please dial the following numbers:888-506-0062 (toll-free) for Canadian ...